Hi all. I have a negative COVID-19 Test Results dated Monday, November 30, 2020. See below:
AB RESULT FOR COVID-19
Pathogen NOT Detected
Status - FINAL COPY
IMMEDIATE CARE CTR OF WESTMONT
DIAGNOSTICS DEPARTMENT
Phone: (630) 324-6825
Fax: (630) 324-6229
29 N CASS AVE
WESTMONT, IL 60559-1669
Date: 11/30/2020
Patient Name:
DOB: 11/08/1965
ID#: 50468
Phone: 630-965-5918
Visit Date Collected / Resulted: 11/30/2020
Diagnosis:
Ordering Physician: ALHUSSAINI,AMER I
OVERALL RESULT: NOT DETECTED
Reference Range: NOT DETECTED
The specimen is NEGATIVE for SARS-CoV-2, the coronavirus associated with COVID-19
TaqPath™ COVID-19 Combo Kit contains the assays and controls for a real-time reverse transcription polymerase chain reaction (RT-PCR) test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens (such as nasopharyngeal, oropharyngeal, nasal, and mid-turbinate swabs, and nasopharyngeal aspirate) and bronchoalveolar lavage (BAL) specimens from individuals suspected of COVID-19 by their healthcare provider. TaqPath™ COVID-19 Combo Kit is for use only under Emergency Use Authorization (EUA). Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity tests.
Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in upper respiratory and bronchoalveolar lavage (BAL) specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease.
Laboratories within the United States and its territories are required to report all positive results to the appropriate public health authorities. Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions.
Negative results must be combined with clinical observations, patient history, and epidemiological information. Testing with the TaqPath™ COVID-19 Combo Kit is intended for use by qualified and trained clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and in vitro diagnostic procedures. The TaqPath™ COVID-19 Combo Kit is only for use under the Food and Drug Administration's Emergency Use Authorization.
Laboratory Director: AMMAR HAMAD MD
IMMEDIATE CARE CENTER OF WESTMONT CLIA# 14D2098020; 29 N CASS AVE, WESTMONT, IL 60559
